Matsuoka T, Matsushita K, Katayama Y, Fujita A, Inageda K, Tanemoto M, Inanobe A, Yamashita S, Matsuzawa Y, Kurachi Y
Departments of Pharmacology II, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Circ Res. 2000 Nov 10;87(10):873-80. doi: 10.1161/01.res.87.10.873.
The ATP-sensitive K(+) (K(ATP)) channels are composed of the pore-forming K(+) channel Kir6.0 and different sulfonylurea receptors (SURs). SUR1, SUR2A, and SUR2B are sulfonylurea receptors that are characteristic for pancreatic, cardiac, and vascular smooth muscle-type K(ATP) channels, respectively. The structural elements of SURs that are responsible for their different characteristics have not been entirely determined. Here we report that the 42 amino acid segment at the C-terminal tail of SURs plays a critical role in the differential activation of different SUR-K(ATP) channels by ADP and diazoxide. In inside-out patches of human embryonic kidney 293T cells coexpressing distinct SURs and Kir6.2, much higher concentrations of ADP were needed to activate channels that contained SUR2A than SUR1 or SUR2B. In all types of K(ATP) channels, diazoxide increased potency but not efficacy of ADP to evoke channel activation. Replacement of the C-terminal segment of SUR1 with that of SUR2A inhibited ADP-mediated channel activation and reduced diazoxide modulation. Point mutations of the second nucleotide-binding domains (NBD2) of SUR1 and SUR2B, which would prevent ADP binding or ATP hydrolysis, showed similar effects. It is therefore suggested that the C-terminal segment of SUR2A possesses an inhibitory effect on NBD2-mediated ADP-induced channel activation, which underlies the differential effects of ADP and diazoxide on K(ATP) channels containing different SURs.
ATP敏感性钾(K(ATP))通道由形成孔道的钾通道Kir6.0和不同的磺脲类受体(SURs)组成。SUR1、SUR2A和SUR2B分别是胰腺、心脏和血管平滑肌型K(ATP)通道特有的磺脲类受体。导致它们具有不同特性的SURs结构元件尚未完全确定。在此我们报告,SURs C末端尾部的42个氨基酸片段在不同SUR-K(ATP)通道被ADP和二氮嗪的差异激活中起关键作用。在共表达不同SURs和Kir6.2的人胚肾293T细胞的内向外膜片中,激活含有SUR2A的通道所需的ADP浓度比激活含有SUR1或SUR2B的通道所需的浓度高得多。在所有类型的K(ATP)通道中,二氮嗪增加了ADP诱发通道激活的效力但不增加其效能。用SUR2A的C末端片段替换SUR1的C末端片段可抑制ADP介导的通道激活并降低二氮嗪的调节作用。SUR1和SUR2B的第二个核苷酸结合结构域(NBD2)的点突变,这会阻止ADP结合或ATP水解,显示出类似的效果。因此表明,SUR2A的C末端片段对NBD2介导的ADP诱导的通道激活具有抑制作用,这是ADP和二氮嗪对含有不同SURs的K(ATP)通道产生不同作用的基础。